The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of patients with stage III non-small cell lung cancer (NSCLC) that harbor a STK11 mutation.
 
Josiah An
No Relationships to Disclose
 
Melissa Yan
No Relationships to Disclose
 
Nanmeng Yu
No Relationships to Disclose
 
Adithya Chennamadhavuni
No Relationships to Disclose
 
Muhammad Furqan
Consulting or Advisory Role - AstraZeneca/MedImmune
Research Funding - Abbvie (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); Biothera (Inst); Celgene (Inst); Genentech (Inst); Genmab (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst)
 
Timothy Kruser
Leadership - Elsevier
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Timothy L Sita
No Relationships to Disclose
 
Ryan Nguyen
No Relationships to Disclose
 
Lawrence Eric Feldman
Research Funding - BrightPath Biotheraputics; E.R. Squibb Sons, LLC (Inst); Genentech (Inst); Merck (Inst); Roche (Inst); Soligenix (Inst)
 
Mary Pasquinelli
No Relationships to Disclose
 
Nasser H. Hanna
Honoraria - UpToDate
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merck KGaA (Inst)
Other Relationship - BeyondSpring Pharmaceuticals; BeyondSpring Pharmaceuticals
 
Taher Abu Hejleh
No Relationships to Disclose